Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.526
-0.000 (-0.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Century Therapeutics Employees
As of December 31, 2024, Century Therapeutics had 150 total employees, including 140 full-time and 10 part-time employees. The number of employees decreased by 15 or -9.09% compared to the previous year.
Employees
150
Change (1Y)
-15
Growth (1Y)
-9.09%
Revenue / Employee
$755,580
Profits / Employee
-$176,547
Market Cap
45.89M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 150 | -15 | -9.09% |
| Dec 31, 2023 | 165 | -19 | -10.33% |
| Dec 31, 2022 | 184 | -4 | -2.13% |
| Dec 31, 2021 | 188 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IPSC News
- 10 days ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 22 days ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 23 days ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 7 weeks ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 3 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - GlobeNewsWire
- 7 months ago - Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire